Collagenases in cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Overall, 2002, Strategies for MMP inhibition in cancer: innovations for the post-trial era, Nat. Rev. Cancer, 2, 657, 10.1038/nrc884
Egeblad, 2002, New functions for the matrix metalloproteinases in cancer progression, Nat. Rev. Cancer, 2, 161, 10.1038/nrc745
Aimes, 1995, Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments, J. Biol. Chem., 270, 5872, 10.1074/jbc.270.11.5872
Ohuchi, 1997, Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules, J. Biol. Chem., 272, 2446, 10.1074/jbc.272.4.2446
Tam, 2004, Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities, J. Biol. Chem., 279, 43336, 10.1074/jbc.M407186200
Chung, 2004, Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis, EMBO J., 23, 3020, 10.1038/sj.emboj.7600318
Knäuper, 1996, Biochemical characterization of human collagenase-3, J. Biol. Chem., 271, 1544, 10.1074/jbc.271.3.1544
Pendás, 1995, The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family, Genomics, 26, 615, 10.1016/0888-7543(95)80186-P
Stolow, 1996, Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development, Mol. Biol. Cell, 10, 1471, 10.1091/mbc.7.10.1471
Springman, 1990, Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation, Proc. Natl. Acad. Sci. USA, 87, 364, 10.1073/pnas.87.1.364
Sanchez-Lopez, 1993, Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins, J. Biol. Chem., 268, 7238, 10.1016/S0021-9258(18)53168-9
Baragi, 1994, Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin, J. Biol. Chem., 269, 12692, 10.1016/S0021-9258(18)99931-X
Nguyen, 1994, Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A, Biochemistry, 33, 2089, 10.1021/bi00174a015
Knäuper, 1997, The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction, J. Biol. Chem., 272, 7608, 10.1074/jbc.272.12.7608
Hirose, 1993, Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity, Proc. Natl. Acad. Sci. USA, 90, 2569, 10.1073/pnas.90.7.2569
Gomis-Rüth, 1996, The helping hand of collagenase-3 (MMP-13): 2.7 Å crystal structure of its C-terminal haemopexin-like domain, J. Mol. Biol., 264, 556, 10.1006/jmbi.1996.0661
Gross, 1962, Collagenolytic activity in amphibian tissues: a tissue culture assay, Proc. Natl. Acad. Sci. USA, 48, 1014, 10.1073/pnas.48.6.1014
Goldberg, 1986, Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein, J. Biol. Chem., 261, 6600, 10.1016/S0021-9258(19)84605-7
Wilhelm, 1986, Human fibroblast collagenase: glycosylation and tissue-specific levels of enzyme synthesis, Proc. Natl. Acad. Sci. USA, 83, 3756, 10.1073/pnas.83.11.3756
McGowan, 1994, Localization of type I human skin collagenase in developing embryonic and fetal skin, J. Invest. Dermatol., 102, 951, 10.1111/1523-1747.ep12384127
Ravanti, 2000, Matrix metalloproteinases in wound repair, Int. J. Mol. Med., 6, 391
Giambernardi, 1998, Overview of matrix metalloproteinase expression in cultured human cells, Matrix Biol., 16, 483, 10.1016/S0945-053X(98)90019-1
Balbín, 2001, Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation, J. Biol. Chem., 276, 10253, 10.1074/jbc.M009586200
Freije, 1994, Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas, J. Biol. Chem., 269, 16766, 10.1016/S0021-9258(19)89457-7
Hasty, 1986, Secreted forms of human neutrophil collagenase, J. Biol. Chem., 261, 5645, 10.1016/S0021-9258(19)57263-5
Hasty, 1990, Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases, J. Biol. Chem., 265, 11421, 10.1016/S0021-9258(19)38413-3
Hasty, 1987, The collagen substrate specificity of human neutrophil collagenase, J. Biol. Chem., 262, 10048, 10.1016/S0021-9258(18)61073-7
Cole, 1996, Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase, J. Biol. Chem., 271, 11023, 10.1074/jbc.271.18.11023
Hanemaaijer, 1997, Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells, J. Biol. Chem., 272, 31504, 10.1074/jbc.272.50.31504
Prikk, 2001, In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis, J. Pathol., 194, 232, 10.1002/path.849
Abe, 2001, Induction of collagenase-2 (matrix metalloproteinase-8) gene expression by interleukin-1β in human gingival fibroblasts, J. Periodontal Res., 36, 153, 10.1034/j.1600-0765.2001.360303.x
Knäuper, 1996, Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme, J. Biol. Chem., 271, 17124, 10.1074/jbc.271.29.17124
Krane, 1996, Different collagenase gene products have different roles in degradation of type I collagen, J. Biol. Chem., 271, 28509, 10.1074/jbc.271.45.28509
Mitchell, 1996, Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage, J. Clin. Invest., 97, 761, 10.1172/JCI118475
Ashworth, 1999, Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling, Biochem. J., 340, 171, 10.1042/0264-6021:3400171
Fosang, 1996, Degradation of cartilage aggrecan by collagenase-3 (MMP-13), FEBS Lett., 380, 17, 10.1016/0014-5793(95)01539-6
McQuibban, 2001, Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1, J. Biol. Chem., 276, 43503, 10.1074/jbc.M107736200
McQuibban, 2000, Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3, Science, 289, 1202, 10.1126/science.289.5482.1202
Deng, 2000, Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library, J. Biol. Chem., 275, 31422, 10.1074/jbc.M004538200
Johansson, 1997, Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development, Dev. Dyn., 208, 387, 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E
Ståhle-Bäckdahl, 1997, Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis, Lab. Invest., 76, 717
Ravanti, 1999, Transforming growth factor-β induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase, J. Biol. Chem., 274, 37292, 10.1074/jbc.274.52.37292
Ravanti, 2001, Human collagenase-3 expression by fetal skin fibroblasts is induced by transforming growth factor-β via p38 mitogen-activated protein kinase, FASEB J., 15, 1098, 10.1096/fj.00-0588fje
Inada, 2004, Critical roles for collagenase-3 (MMP13) in development of growth plate cartilage and in endochondral ossification, Proc. Natl. Acad. Sci. U. S. A., 101, 17192, 10.1073/pnas.0407788101
Stickens, 2004, Altered endochondral bone development in matrix metalloproteinase 13-deficient mice, Development, 131, 5883, 10.1242/dev.01461
Lindy, 1997, Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium, Arthritis Rheum., 40, 1391, 10.1002/art.1780400806
Mao, 1999, Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture, Biochem. Biophys. Res. Commun., 261, 904, 10.1006/bbrc.1999.1142
Reboul, 1996, The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis, J. Clin. Invest., 97, 2011, 10.1172/JCI118636
Sukhova, 1999, Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques, Circulation, 99, 2503, 10.1161/01.CIR.99.19.2503
Uitto, 1998, Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation, Am. J. Path., 152, 1489
Vaalamo, 1998, Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophagemetalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations, Am. J. Pathol., 152, 1005
Vaalamo, 1997, Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds, J. Invest. Dermatol., 109, 96, 10.1111/1523-1747.ep12276722
Karin, 1997, AP-1 function and regulation, Curr. Opin. Cell Biol., 9, 240, 10.1016/S0955-0674(97)80068-3
Sharrocks, 1997, The ETS-domain transcription factor family, Int. J. Biochem. Cell Biol., 29, 1371, 10.1016/S1357-2725(97)00086-1
Wasylyk, 1991, The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins, EMBO J., 10, 1127, 10.1002/j.1460-2075.1991.tb08053.x
Westermarck, 1997, Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors, Oncogene, 14, 2651, 10.1038/sj.onc.1201111
Kaya, 1996, A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells, Oncogene, 12, 221
Buttice, 1996, Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex, Oncogene, 13, 2297
Gum, 1996, Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences, J. Biol. Chem., 271, 10672, 10.1074/jbc.271.18.10672
Bolon, 1995, Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas, Am. J. Pathol., 147, 1298
Bolon, 1996, Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions, Lab. Invest., 75, 1
Wernert, 1994, Stromal expression of c-Ets1 transcription factor correlates with tumor invasion, Cancer Res., 54, 5683
Korzus, 1997, The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression, J. Biol. Chem., 272, 1188, 10.1074/jbc.272.2.1188
Westermarck, 2001, mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase-1 (MMP-1) gene expression, Mol. Cell. Biol., 21, 2373, 10.1128/MCB.21.7.2373-2383.2001
Uría, 1997, Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions, Cancer Res., 57, 4882
Uría, 1998, Differential effects of transforming growth factor-β on the expression of collagenase-1 and collagenase-3 in human fibroblasts, J. Biol. Chem., 273, 9769, 10.1074/jbc.273.16.9769
Pendás, 1997, Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13), Genomics, 40, 222, 10.1006/geno.1996.4554
Ducy, 1997, Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation, Cell, 89, 747, 10.1016/S0092-8674(00)80257-3
Komori, 1997, Targeted disrubtion of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts, Cell, 89, 755, 10.1016/S0092-8674(00)80258-5
Jiménez, 1999, Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation, Mol. Cell. Biol., 19, 4431, 10.1128/MCB.19.6.4431
Selvamurugan, 2004, Transforming growth factor-β1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2, J. Biol. Chem., 279, 19327, 10.1074/jbc.M314048200
Mengshol, 2001, IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways, Nucleic Acids Res., 29, 4361, 10.1093/nar/29.21.4361
El-Deiry, 1992, Definition of a consensus binding site for p53, Nat. Genet., 1, 45, 10.1038/ng0492-45
Kley, 1992, Repression of the basal c-fos promoter by wild-type p53, Nucleic Acids Res., 20, 4083, 10.1093/nar/20.15.4083
Miyashita, 1994, Identification of a p53-dependent negative response element in the bcl-2 gene, Cancer Res., 54, 3131
Werner, 1996, Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene, Proc. Natl. Acad. Sci. USA, 93, 8318, 10.1073/pnas.93.16.8318
Sun, 2004, P53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex, J. Cell. Biochem., 92, 258, 10.1002/jcb.20044
Sun, 1999, p53 down-regulates human matrix metalloproteinase-1 (Collagenase-1) gene expression, J. Biol. Chem., 274, 11535, 10.1074/jbc.274.17.11535
Sun, 2000, Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13), J. Biol. Chem., 275, 11327, 10.1074/jbc.275.15.11327
Ala-aho, 2002, Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells, Oncogene, 21, 1187, 10.1038/sj.onc.1205198
Vincenti, 1994, Regulation of collagenase gene expression by IL-1β requires transcriptional and post-transcriptional mechanisms, Nucleic Acids Res., 22, 4818, 10.1093/nar/22.22.4818
Reunanen, 2002, Activation of p38α MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization, J. Biol. Chem., 277, 32360, 10.1074/jbc.M204296200
Frevel, 2003, p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts, Mol. Cell. Biol., 23, 425, 10.1128/MCB.23.2.425-436.2003
Carballo, 2000, Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability, Blood, 95, 1891, 10.1182/blood.V95.6.1891
Lai, 1999, Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA, Mol. Cell. Biol., 19, 4311, 10.1128/MCB.19.6.4311
Stoecklin, 2000, Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway, Mol. Cell. Biol., 20, 3753, 10.1128/MCB.20.11.3753-3763.2000
Rydziel, 2004, AU-rich elements in the collagenase 3 mRNA mediate stabilization of the transcript by cortisol in osteoblasts, J. Biol. Chem., 279, 5397, 10.1074/jbc.M311984200
Van Wart, 1990, The cystein switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family, Proc. Natl. Acad. Sci. USA, 87, 5578, 10.1073/pnas.87.14.5578
Suzuki, 1990, Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin), Biochemistry, 29, 10261, 10.1021/bi00496a016
Ito, 1988, Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase, Arch. Biochem. Biophys., 267, 211, 10.1016/0003-9861(88)90025-2
Imai, 1995, Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties, J. Biol. Chem., 270, 6691, 10.1074/jbc.270.12.6691
Saarinen, 1994, Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase, J. Biol. Chem., 269, 18134, 10.1016/S0021-9258(17)32427-4
D'Ortho, 1997, Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases, Eur. J. Biochem., 250, 751, 10.1111/j.1432-1033.1997.00751.x
Knäuper, 1997, Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13), Eur. J. Biochem., 248, 369, 10.1111/j.1432-1033.1997.00369.x
Baker, 2002, Metalloproteinase inhibitors: biological actions and therapeutic opportunities, J. Cell Sci., 115, 3719, 10.1242/jcs.00063
Butler, 1999, The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations, J. Biol. Chem., 274, 20391, 10.1074/jbc.274.29.20391
Stratmann, 2001, MMP-TIMP interaction depends on residue 2 in TIMP-4, FEBS Lett., 507, 285, 10.1016/S0014-5793(01)02987-8
Vihinen, 2002, Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets, Int. J. Cancer, 99, 157, 10.1002/ijc.10329
Barsky, 1983, Loss of basement membrane components by invasive tumors but not by their benign counterparts, Lab. Invest., 49, 140
Chambers, 2002, Dissemination and growth of cancer cells in metastatic sites, Nat. Rev. Cancer, 2, 563, 10.1038/nrc865
He, 2004, Role of lymphangiogenic factors in tumor metastasis, Biochim. Biophys. Acta, 1654, 3
Guo, 1997, Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells, J. Biol. Chem., 272, 24, 10.1074/jbc.272.1.24
Murray, 1996, Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer, Nat. Med., 2, 461, 10.1038/nm0496–461
Murray, 1998, Matrix metalloproteinases and their inhibitors in gastric cancer, Gut, 43, 791, 10.1136/gut.43.6.791
Murray, 1998, Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer, J. Pathol., 185, 256, 10.1002/(SICI)1096-9896(199807)185:3<256::AID-PATH115>3.0.CO;2-A
Ito, 1999, Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor, Mod. Pathol., 12, 669
Nikkola, 2002, High expression levels of collagenase-1 (MMP-1) and stromelysin-1 (MMP-3) correlate with shorter disease-free survival in human metastatic melanoma, Int. J. Cancer, 97, 432, 10.1002/ijc.1636
Nikkola-Paakkarinen, 2005, Prognostic value of serum gelatinase-B (MMP-9) and collagenase-1 (MMP-1) and collagenase-3 (MMP-13) in human metastatic melanoma, Clin. Cancer Res.
Johansson, 1997, Expression of collagenase-3 (matrix metalloproteinase-13) in squamos cell carcinomas of the head and neck, Am. J. Pathol., 151, 499
Muller, 1991, Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours, Int. J. Cancer, 48, 550, 10.1002/ijc.2910480412
Polette, 1991, Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization, Invasion Metastasis, 11, 76
Kang, 2003, A multigenic program mediating breast cancer metastasis to bone, Cancer Cell, 3, 537, 10.1016/S1535-6108(03)00132-6
Rutter, 1998, A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription, Cancer Res., 58, 5321
Ghilardi, 2001, Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness, Clin. Cancer Res., 7, 2344
Kanamori, 1999, Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region, Cancer Res., 59, 4225
Nishioka, 2000, A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas, Jpn. J. Cancer Res., 91, 612, 10.1111/j.1349-7006.2000.tb00989.x
Moilanen, 2002, Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinoma, J. Pathol., 197, 72, 10.1002/path.1078
Stadlmann, 2003, Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer, Eur. J. Cancer, 39, 2499, 10.1016/j.ejca.2003.08.011
Balbín, 2003, Loss of collagenase-2 confers increased skin tumor susceptibility to male mice, Nat. Genet., 35, 252, 10.1038/ng1249
Nielsen, 2001, Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas, Cancer Res, 61, 7091
Airola, 1997, Human collagenase-3 is expressed in malignant squamous epithelium of the skin, J. Invest. Dermatol., 109, 225, 10.1111/1523-1747.ep12319441
Cazorla, 1998, Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx, J. Pathol., 186, 144, 10.1002/(SICI)1096-9896(1998100)186:2<144::AID-PATH147>3.0.CO;2-#
Johansson, 1999, Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas, Am. J. Pathol., 154, 469, 10.1016/S0002-9440(10)65293-5
Etoh, 2000, Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness, Gut, 47, 50, 10.1136/gut.47.1.50
Uría, 1998, Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor, Am. J. Pathol., 153, 91, 10.1016/S0002-9440(10)65549-6
Airola, 1999, Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas, Br. J. Cancer, 80, 733, 10.1038/sj.bjc.6690417
Nikkola, 2001, High collagenase-1 expression correlates with a favourable chemoimmunotherapy response in human metastatic melanoma, Melanoma Res., 11, 157, 10.1097/00008390-200104000-00011
Boström, 2000, Expression of collagenase-3 (matrix metalloproteinase-13) in transitional cell carcinoma of the urinary bladder, Int. J. Cancer, 88, 417, 10.1002/1097-0215(20001101)88:3<417::AID-IJC14>3.0.CO;2-G
Johansson, 1997, Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT Keratinocytes is enchanced by tumor necrosis factor-α and transforming growth factor−β, Cell Growth Differ., 8, 243
Ala-aho, 2004, Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo, Oncogene, 23, 5111, 10.1038/sj.onc.1207678
Ala-aho, 2000, Inhibition of collagenase-3 (MMP-13) expression in transformed human keratinocytes by interferon-γ is associated with activation of extracellular signal-regulated kinase-1,2 and STAT1, Oncogene, 19, 248, 10.1038/sj.onc.1203306
McCawley, 2001, Matrix metalloproteinases: they're not just for matrix anymore!, Curr. Opin. Cell Biol., 13, 534, 10.1016/S0955-0674(00)00248-9
Parks, 2004, Matrix metalloproteinases as modulators of inflammation and innate immunity, Nat. Rev. Immunol., 4, 617, 10.1038/nri1418
Sabeh, 2004, Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP, J. Cell Biol., 167, 769, 10.1083/jcb.200408028
Kalluri, 2003, Basement membranes: structure, assembly and role in tumour angiogenesis, Nat. Rev. Cancer, 3, 422, 10.1038/nrc1094
Hidalgo, 2001, Development of matrix metalloproteinase inhibitors in cancer therapy, J. Natl. Cancer Inst., 93, 178, 10.1093/jnci/93.3.178
Vihinen, 2005, Matrix metalloproteinases as therapeutic targets in cancer, Curr. Cancer Drug Targets, 10.2174/1568009053765799
Bramhall, 2002, Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial, Br. J. Cancer, 86, 1864, 10.1038/sj.bjc.6600310
Rowinsky, 2000, Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies, J. Clin. Oncol., 18, 178, 10.1200/JCO.2000.18.1.178
Lokeshwar, 2001, Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3), Curr. Med. Chem., 8, 271, 10.2174/0929867013373516
Lokeshwar, 2002, Inhibition of cell4proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model, Int. J. Cancer, 98, 297, 10.1002/ijc.10168
Seftor, 1998, Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis, Clin. Exp. Metastasis, 16, 217, 10.1023/A:1006588708131
Delmas, 1996, Bisphosphonates in the treatment of bone diseases, N. Engl. J. Med., 335, 1836, 10.1056/NEJM199612123352409
Teronen, 1999, MMP inhibition and downregulation by bisphosphonates, Ann. N. Y. Acad. Sci., 878, 453, 10.1111/j.1749-6632.1999.tb07702.x
Gingras, 2001, Matrix proteinase inhibition by AE-941, a multifunctional antiangiogenic compound, Anticancer Res., 21, 145
Ala-aho, 2002, Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells, Int. J. Cancer, 97, 283, 10.1002/ijc.1619
Ahonen, 1998, Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells, Cancer Res., 58, 2310
Ahonen, 2002, Antitumor activity and by-stander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3, Mol. Ther., 6, 705, 10.1006/mthe.2002.0606
Brand, 2000, Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue, Cancer Res., 60, 5723
Bloomston, 2002, TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis, J. Surg. Res., 102, 39, 10.1006/jsre.2001.6318
Wang, 1997, Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4, Oncogene, 14, 2767, 10.1038/sj.onc.1201245
Celiker, 2001, Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA, Oncogene, 20, 4337, 10.1038/sj.onc.1204508
Johansson, 2000, Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase, J. Cell Sci., 113, 227, 10.1242/jcs.113.2.227
Clayman, 1995, In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma, Cancer Res., 55, 1
Clayman, 1998, Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma, J. Clin. Oncol., 16, 2221, 10.1200/JCO.1998.16.6.2221
Clayman, 1999, Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers, Clin. Cancer Res., 5, 1715
Liu, 1994, Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus, Cancer Res., 54, 3662
Liu, 1995, Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck, Cancer Res., 55, 3117
Lane, 2002, Therapeutic exploitation of the p53 pathway, Trends Mol. Med., 8, S38, 10.1016/S1471-4914(02)02309-2
Hasegawa, 1998, Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model, Int. J. Cancer, 76, 812, 10.1002/(SICI)1097-0215(19980610)76:6<812::AID-IJC8>3.0.CO;2-0
James, 1995, RNA enzymes as tools for gene ablation, Curr. Opin. Biotechnol., 6, 44, 10.1016/0958-1669(95)80008-5
Flory, 1996, Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint, Proc. Natl. Acad. Sci. USA, 93, 754, 10.1073/pnas.93.2.754
Hua, 1996, Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system, Cancer Res., 56, 5279